STI571

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Novartis PharmaceuticalsPhase 2

—

Rating in progress

STI571 in Leukemia, Myelogenous, Chronic, BCR-ABL Positive is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Dormant